Shareholder alert: weiss law investigates equillium, inc.

New york,, nov. 23, 2022 /prnewswire/ -- weiss law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of equillium, inc. ("equillium" or the "company") (nasdaq: eq), in connection with its takeover of metacrine, inc. (metacrine) (nasdaq: mtcr). under the terms of the merger agreement, equillium will issue stock valued at a 25% premium over the metacrine net cash delivered at closing, which is estimated to be approximately $26 million.
EQ Ratings Summary
EQ Quant Ranking